Search Results - "McGinn, Arlo N."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Feeding Tube Placement: Errors and Complications by Stayner, James L., Bhatnagar, Akash, McGinn, Arlo N., Fang, John C.

    Published in Nutrition in clinical practice (01-12-2012)
    “…Feeding tube placement for enteral nutrition (EN) support is widely used in both critically ill and stable chronically ill patients who are unable to meet…”
    Get full text
    Journal Article
  2. 2

    Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia by Won, Young-Wook, McGinn, Arlo N, Lee, Minhyung, Nam, Kihoon, Bull, David A, Kim, Sung Wan

    Published in Biomaterials (01-08-2013)
    “…Abstract Vascular endothelial growth factor (VEGF) gene therapy to promote therapeutic angiogenesis has been advanced as an alternative treatment for…”
    Get full text
    Journal Article
  3. 3

    Targeted Gene Delivery to Ischemic Myocardium by Homing Peptide-Guided Polymeric Carrier by Won, Young-Wook, McGinn, Arlo N, Lee, Minhyung, Bull, David A, Kim, Sung Wan

    Published in Molecular pharmaceutics (07-01-2013)
    “…Myocardial ischemia needs an alternative treatment such as gene therapy for the direct protection of cardiomyocytes against necrosis or apoptosis and to…”
    Get full text
    Journal Article
  4. 4

    Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats by Lee, Youngsook, McGinn, Arlo N., Olsen, Curtis D., Nam, Kihoon, Lee, Minhyung, Shin, Sug Kyun, Kim, Sung Wan

    Published in Journal of controlled release (10-10-2013)
    “…Considerable efforts have been made to exploit cardioprotective drugs and gene delivery systems for myocardial infarction (MI). The promising cardioprotective…”
    Get full text
    Journal Article
  5. 5

    Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium by McGinn, Arlo N, Nam, Hye Yeong, Ou, Mei, Hu, Norman, Straub, Catherine M, Yockman, James W, Bull, David A, Kim, Sung Wan

    Published in Biomaterials (01-01-2011)
    “…Abstract Implantation of skeletal myoblasts to the heart has been investigated as a means to regenerate and protect the myocardium from damage after myocardial…”
    Get full text
    Journal Article
  6. 6

    Abstract 2756: Synergistic tumor-suppressive effect of apatinib, a selective VEGFR-2 inhibitor, in combination with immunotherapy in a syngeneic murine lung cancer model by Kim, Bumjin, McGinn, Arlo N., Park, Cheol Hee, Kim, Sung Chul

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Anti-angiogenesis therapy is considered one of several promising combination strategies with immunotherapy. The potential for synergistic combination is based…”
    Get full text
    Journal Article
  7. 7

    A phase I study to evaluate the pharmacokinetics of a new oncology nce, apatinib mesylate tablets, with and without food following single and multiple doses in healthy subjects by Pesco Koplowitz, Luana, Koplowitz, Barry, Park, Cheol Hee, McGinn, Arlo N.

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e14049 Background: Apatinib Mesylate (YN968D1) is a selective inhibitor of VEGFR-2 being developed for the treatment of advanced gastric cancer…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Human Erythropoietin Gene Delivery for Cardiac Remodeling of Myocardial Infarction in Rats by Lee, Youngsook, McGinn, Arlo N, Olsen, Curtis D, Nam, Kihoon, Lee, Minhyung, Shin, Sug Kyun, Kim, Sung Wan

    Published in Molecular therapy (01-09-2013)
    “…Background: Considerable efforts have been made to exploit cardioprotective drugs and gene delivery systems for myocardial infarction. The promising…”
    Get full text
    Journal Article
  11. 11

    Feeding Tube Placement by Stayner, James L., Bhatnagar, Akash, McGinn, Arlo N., Fang, John C.

    Published in Nutrition in clinical practice (01-12-2012)
    “…Feeding tube placement for enteral nutrition (EN) support is widely used in both critically ill and stable chronically ill patients who are unable to meet…”
    Get full text
    Journal Article